Endothelial progenitor cells in diabetic foot syndrome

Advances in Clinical and Experimental Medicine

Volumn 21, Issue 2, 2012, Pages 249-254

  Drela, Ewelina ^a   Stankowska, Katarzyna ^a   Kulwas, Arleta ^a   Rość, Danuta ^a  

^a NICOLAUS COPERNICUS UNIVERSITY   (Poland)

Author keywords

Diabetic foot syndrome; Endothelial progenitor cells

Indexed keywords

ANGIOGENIC FACTOR; VASCULOTROPIN;

ANGIOGENESIS; BONE MARROW CELL; CELL ADHESION; CELL MIGRATION; CELL PROLIFERATION; DIABETIC FOOT; ENDOTHELIAL PROGENITOR CELL; HEMATOPOIETIC CELL; HEMOSTASIS; HUMAN; ISCHEMIA; NEOVASCULARIZATION (PATHOLOGY); PATHOGENESIS; PATHOPHYSIOLOGY; REVIEW;

EID: 84862530569     PISSN: 18995276     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (26)

1. Pearson JD: Endothelial progenitor cells - hype or hope? J Thromb Haemost 2009, 7, 255-262.
2. Urbich C, Dimmeler S: Endothelial progenitor cells: characterization and roles in vascular biology. Circ Res 2004, 95, 343-353.
3. Fadini GP, Sartore S, Agostini C, Avogaro A: Significance of endothelial progenitor cells in subjects with diabetes. Diabetes Care 2007, 5, 1305-1312.
4. Friedrich EB, Walenta K, Scharlau J, Nickenig G, Werner N: CD34-/CD133 +VEGFR- 2 + Endothelial progenitor cell subpopulation with potent vasoregenerative capacities. Circ Res 2006, 98, e20-e25.
5. Silvestre JS: Vascular progenitor cells and diabetes: roles in postischemnic neovascularization. Diab Metabol 2008 34, 533-536.
6. Ding H, Triggle Ch: R. Endothelial cell dysfunction and the vascular complications associated with type 2 diabetes: assessing the health of the endothelium. Vasc Health Risk Manag 2005, 1, 55-71.
7. Ranjan AK, Kumar U, Hardikar AA, Poddar P, Nair PD, Hardikar AA: Human blood vessel-derived endothelial progenitors for endothelialization of small diameter vascular prosthesis. PLoS One 2009, 4(11), e7718.
8. Murohara T, Ikeda H, Duan J, Shintani S, Sasaki K, Equchi H, Onitsuka I, Matsui K, Imaizumi T: Transplanted cord blood-derived endothelial precursor cells augment postnatal neovascularization. J Clin Invest 2000, 105, 1527-1536.
9. Shi Q, Rafii S, Wu MH, Wijelath ES, Yu C, Ishiola A, Fujita Y, Kothari S, Mohle R, Sauvage LR, Moore MA, Storb RF, Hammond WP: Evidence for circulating bone marrow-derived endothelial cells. Blood 1998, 92, 362-367.
10. Planat-Benard V, Silvestre JS, Cousin B, Andre M, Nibbelink M, Tamarat M, Clerque M, Manneville C, Sailla-Barreau C, Duriez M, Tedqui A, Levy B, Penicaud L, Casteilla L: Plasticity of human adipose lineage cells toward endothelial cells: physiological and therapeutic perspectives. Circulation 2004, 109, 656-663.
11. Majka SM, Jackson KA, Kienstra KA, Majesky MW, Goodell MA, Goodell MA, Hirschi KK: Distinct progenitor populations in skeletal muscle are bone marrow derived and exhibit different cell fates during vascular regeneration. J Clin Invest 2003, 111, 71-79.
12. Beltrami AP, Barlucchi L, Torella D, Baker M, Limana F, Chimenti S, Kasahara H, Rota M, Musso E, Urbanek K, Leri A, Kajstura I, Nadal-Ginard B, Anversa P: Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 2003, 114, 763-776.
13. Werner N, Junk S, Laufs U, Link A, Walenta K, Bohm M, Nickenig G: Intravenous transfusion of endothelial progenitor cells reduces neointima formation after vascular injury. Circ Res 2003, 93, e17-24.
14. Churdchomjan W, Kheloamai P, Manochantr S, Tapanadechopone ChP, Tantrawatpan CH, U-pratya Y, Issaragrisil S: Comparison of endothelial progenitor cell function in type 2 diabetes with good and poor glycemic control. BMC Endocr Dis 2010, 10, 5.
15. Gallagher KA, Liu ZJ, Xiao M, Chen H, Goldstein LJ, Buerk DG, Nedeau A, Thom SR, Velazquez OC: Diabetic impairments in NO-mediated endothelail progenitor cell mobilization and homing are reversed in order to hyperoxia and SDF-1 α. J Clin Invest 2007, 117, 1249-1259.
16. Liu ZJ, Velazquez OC: Hyperoxia, endothelial progenitor cell mobilization, and diabetic wound healing. Antioxid Redox Signal 2008, 10, 1869-1882.
17. Loomans C, van Haperen R, Duijs JM, Verseyden C, de Crom R, Leenen P, Drexhage HA, de Boer HC, de Koning EJP, Rabelink TJ, Staal FJT, van Zonneveld AJ: Differentiation of bone marrow-derived endothelial progenitor cells is shifted into proinflammatory phenotype in order to hyperglycemia. Mol Med 2009, 15, 152-159.
18. Tepper OM, Galiano RD, Capla JM, Kalka Ch, Gagne PJ, Jacobovitz GR, Levine JP, Gurther GC: Human endothelial progenitor cells from type 2 diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures. Circulation 2002, 106, 2781-2786.
19. Yan J, Tie G, Park B, Yang Y, Nowicki PT, Messina LM: Recovery from hindlimb ischemia is less effective in type 2 than in type 1 diabetic mice: roles of eNOS and endothelial progenitor cells. J Vasc Surg 2009, 50, 1412-1422.
20. Karnafel W: Diabetic foot-pathogenesis and treatment. Lekarz 2009, 11, 26-32.
21. Fadini GP, Miorin M, Facco M, Bonamico S, Baesso I, Grego F, Menegolo M, de Kreutzenberg SV, Tiengo A, Agostini C, Avogaro A: Circulating endothelial progenitor cells are reduced in peripheral vascular complications of type 2 diabetes mellitus. J Am Coll Card 2005, 9, 1449-1457.
22. Krankel N, Adams V, Linke A, Gielen S, Erbs S, Lenk K, Schuler G, Hambrecht R: Hyperglycemia reduces survival and impairs function of circulating blood-derived progenitor cells. Arterioscler Thromb Vasc Biol 2005, 25, 698-703.
23. Caballero S, Sengupta N, Afzal A, Chang KH, Li Calzi S, Guberski DL, Kern TS, Grant MB: Ischemic vascular damage can be repaired by healthy, but not diabetic endothelial progenitor cells. Diabetes 2007, 56, 960-967.
24. Spinetti G, Kraenkel N, Emanueli C, Madeddu P: Diabetes and vessel wall remodeliling: from mechanistic insights to regenerative therapies. Cardiovasc Res 2008, 78.
25. Fadini GP, Sartore S, Baesso I, Lenzi M, Agostini C, Tiengo A, Avogaro A: Endothelial progenitor cells and the diabetic paradox. Diabetes Care 2006, 3, 714-716.
26. Humpert PM, Battista MJ, Lammert A, Reismann P, Djuric Z, Rudofsky G Jr, Zorn M, Morcos M, Hamnies HP, Nawroth PP, Bierhaus A: Association of stromal cell-derived factor 1 genotype with diabetic foot syndrome and macrovascular disease in patients with type 2 diabetes. Clin Chem 2006, 52 (6), 1206-8.